/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of around $36 billion, ResMed Inc. (RMD) is a global leader in the design, manufacture, and distribution of medical devices and cloud-based software solutions for the treatment of sleep-disordered breathing and other chronic respiratory conditions. The company operates through two primary segments - Sleep and Respiratory Care and Software-as-a-Service, serving patients and healthcare providers worldwide.
Shares of the San Diego, California-based company have outperformed the broader market over the past 52 weeks. RMD has increased 12.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained 10.1%. Moreover, ResMed stock has risen 7.4% on a YTD basis, compared to SPX's marginal decline.